You are here

Merck

Keytruda Is Top Therapy for Melanoma in US

Yahoo/Market Realist

Mon, 12/14/15 - 10:13 am

Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds

Yahoo/Benzinga

Sun, 12/13/15 - 11:13 am

Bristol-Myers Squibb

Bayer looks to bone up in oncology after slipping behind rivals

Fierce Biotech

Sat, 12/12/15 - 01:51 pm

Bristol-Myers Squibb

Lilly and Merck pair 'breakthrough' therapies in latest cancer collaboration

Fierce Pharma

Fri, 12/11/15 - 10:46 pm

FDA’s Target Action Date for Merck’s Keytruda Is December 24

Yahoo/Market Realist

Fri, 12/11/15 - 10:24 pm

Balance Sheet Brawl: Merck & Co. Takes on Eli Lilly

Motley Fool

Fri, 12/11/15 - 09:41 am

With Paris spotlight on climate change, here's how Big Pharma stacks up

Fierce Pharma

Wed, 12/9/15 - 11:46 am

Bristol-Myers Squibb

Merck's Keytruda gets presidential lift as Jimmy Carter announces he's cancer-free

BioPharma Dive

Mon, 12/7/15 - 12:09 pm

cancer immunotherapy

Amgen and Merck & Co to Collaborate for Immunotherapy Cancer

Bidness, ETC

Fri, 12/4/15 - 08:20 pm

cancer immunotherapy

Merck CEO: In Healthcare, We Cannot Afford to Fail

Forbes

Thu, 12/3/15 - 09:33 am

Kenneth Frazier

3 Leaders In Alzheimer's BACE Inhibition

Seeking Alpha

Wed, 12/2/15 - 11:05 am

Alzheimer's disease

BACE inhibitors

Merck, J&J and Lilly shares climb after upgrades at Barclays

Marketwatch

Tue, 12/1/15 - 01:01 pm

Keytruda: Hope for Merck’s Immuno-Oncology Franchise

Yahoo/Market Realist

Fri, 11/27/15 - 12:03 pm

immuno-oncology

New medicine for house dust mite allergic rhinitis now available in Japan

Yahoo

Fri, 11/27/15 - 11:57 am

allergic rhinitis

Merck Announces Initial Results for KEYTRUDA® (pembrolizumab) with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress

Yahoo

Sun, 11/22/15 - 10:48 am

Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer

Motley Fool

Sun, 11/22/15 - 10:47 am

cancer immunotherapies

Bristol-Myers Squibb

targeted therapies

Threshold Pharmaceuticals

Gilead Sciences: AbbVie, Merck Fail to ‘Mount a Major Threat’

Barron's

Wed, 11/18/15 - 03:53 pm

Gilead Sciences

Is Merck & Co A Bigger-Than-Expected Threat To Gilead Sciences In HCV?

Bidness, ETC

Mon, 11/16/15 - 03:36 pm

Gilead Sciences

grazoprevir/elbasvir

Biogen Who Can Acquire It And Who It Can Acquire

Bidness, ETC

Mon, 11/16/15 - 10:42 am

Acorda Therapeutics

Study Shows Merck Hepatitis C Drug Cures Addicts

Bloomberg

Mon, 11/16/15 - 09:00 am

Pages